| scholarly article | Q13442814 |
| P2093 | author name string | José Mengel | |
| Rosa Teixeira de Pinho | |||
| Fabíola Cardillo | |||
| Paulo Renato Zuquim Antas | |||
| P2860 | cites work | Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G (Gr1(+))CD11b(+ )immature myeloid suppressor cells | Q58846150 |
| Glycosylphosphatidylinositol-anchored mucin-like glycoproteins from Trypanosoma cruzi bind to CD1d but do not elicit dominant innate or adaptive immune responses via the CD1d/NKT cell pathway | Q58846153 | ||
| Chagas' disease | Q58846530 | ||
| T-cell repertoire analysis in acute and chronic human Chagas' disease: differential frequencies of Vbeta5 expressing T cells | Q58846821 | ||
| A monoclonal antibody defining antigenic determinants on subpopulations of mammalian neurones and Trypanosoma cruzi parasites | Q58847482 | ||
| Strain-specific TCR repertoire selection of IL-4-producing Thy-1dull γ δ thymocytes | Q61640265 | ||
| The homogeneity of the TCRδ repertoire expressed by the Thy-1dull γ δ T cell population is due to cellular selection | Q61640268 | ||
| An activated murine B cell lymphoma line (A-20) produces a factor-like activity which is functionally related to human natural killer cell stimulatory factor | Q67523796 | ||
| Genetic mapping of two murine loci that influence the development of IL-4-producing Thy-1dull gamma delta thymocytes | Q73910700 | ||
| Immunity, autoimmunity and inflammatory bowel disease | Q86969204 | ||
| Low-dose interleukin-2 therapy: a driver of an imbalance between immune tolerance and autoimmunity | Q27008200 | ||
| Environmental microbes and uveitis: is microbial exposure always bad? | Q28086831 | ||
| Chagas disease | Q29615136 | ||
| Tolerogenic dendritic cells | Q29618755 | ||
| Invariant NKT cells sustain specific B cell responses and memory | Q30479030 | ||
| Profile of central and effector memory T cells in the progression of chronic human chagas disease | Q33501719 | ||
| IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis | Q33532584 | ||
| Critical proinflammatory and anti-inflammatory functions of different subsets of CD1d-restricted natural killer T cells during Trypanosoma cruzi infection. | Q33558006 | ||
| Tumor necrosis factor-α confers cardioprotection through ectopic expression of keratins K8 and K18. | Q33641786 | ||
| Both CD1d antigen presentation and interleukin-12 are required to activate natural killer T cells during Trypanosoma cruzi infection | Q33716129 | ||
| DX5+NKT cells display phenotypical and functional differences between spleen and liver as well as NK1.1-Balb/c and NK1.1+ C57Bl/6 mice | Q33884869 | ||
| Regulatory T cells phenotype in different clinical forms of Chagas' disease | Q33927456 | ||
| Acute chagas disease: new global challenges for an old neglected disease | Q33981753 | ||
| Natural killer T cells and innate immune B cells from lupus-prone NZB/W mice interact to generate IgM and IgG autoantibodies | Q34043615 | ||
| Immunoregulatory networks in human Chagas disease | Q34084644 | ||
| Antigen-recognition properties of murine gamma delta T cells | Q34104912 | ||
| During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein | Q34115997 | ||
| Murine CD27(-) Vγ6(+) γδ T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages | Q34119854 | ||
| Benznidazole treatment following acute Trypanosoma cruzi infection triggers CD8+ T-cell expansion and promotes resistance to reinfection | Q34252265 | ||
| Regulation of T cell immunity by dendritic cells | Q34339191 | ||
| Immunomodulation by Trypanosoma cruzi: toward understanding the association of dendritic cells with infecting TcI and TcII populations | Q34413237 | ||
| Activation of natural killer T cells by alpha-galactosylceramide impairs DNA vaccine-induced protective immunity against Trypanosoma cruzi | Q34714252 | ||
| Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease | Q34783795 | ||
| A human type 5 adenovirus-based Trypanosoma cruzi therapeutic vaccine re-programs immune response and reverses chronic cardiomyopathy | Q35009081 | ||
| Deficiency of antigen-specific B cells results in decreased Trypanosoma cruzi systemic but not mucosal immunity due to CD8 T cell exhaustion | Q35071882 | ||
| Antigen targeting to dendritic cells allows the identification of a CD4 T-cell epitope within an immunodominant Trypanosoma cruzi antigen | Q35095495 | ||
| Cytokine profiling in Chagas disease: towards understanding the association with infecting Trypanosoma cruzi discrete typing units (a BENEFIT TRIAL sub-study). | Q35114499 | ||
| Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells | Q35462159 | ||
| Probiotics and antibiotics in IBD. | Q35532095 | ||
| Murine IL-17+ Vγ4 T lymphocytes accumulate in the lungs and play a protective role during severe sepsis | Q35650392 | ||
| IL-10 limits parasite burden and protects against fatal myocarditis in a mouse model of Trypanosoma cruzi infection | Q35659197 | ||
| Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice | Q35689168 | ||
| B-Cell Response during Protozoan Parasite Infections | Q35725257 | ||
| Trypanosoma cruzi-induced immunosuppression: blockade of costimulatory T-cell responses in infected hosts due to defective T-cell receptor-CD3 functioning | Q35777349 | ||
| A novel ABCG-like transporter of Trypanosoma cruzi is involved in natural resistance to benznidazole | Q35810796 | ||
| Chronic chagasic myocarditis pathogenesis: dependence on autoimmune and microvascular factors | Q35857887 | ||
| Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry | Q36385476 | ||
| γδT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer. | Q36473289 | ||
| Developing and maintaining protective CD8+ memory T cells. | Q36528975 | ||
| Trypanosoma cruzi induces regulatory dendritic cells in vitro | Q36710772 | ||
| Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORγt and Ahr that leads to IL-17 production by activated B cells | Q36781300 | ||
| Epigenetic and transcriptional signatures of stable versus plastic differentiation of proinflammatory γδ T cell subsets | Q36807846 | ||
| Trypanosoma cruzi infection from the view of CD8+ T cell immunity--an infection model for developing T cell vaccine | Q36922758 | ||
| Do self-heart-reactive T cells expand in Trypanosoma cruzi-immune hosts? | Q37005726 | ||
| Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function | Q37094107 | ||
| Chagas heart disease pathogenesis: one mechanism or many? | Q37264799 | ||
| Stable CD8+ T cell memory during persistent Trypanosoma cruzi infection | Q37326226 | ||
| Cytokine-producing effector B cells regulate type 2 immunity to H. polygyrus. | Q37349889 | ||
| From vaccines to memory and back | Q37804530 | ||
| Antigen Mimicry between Infectious Agents and Self or Environmental Antigens May Lead to Long-Term Regulation of Inflammation | Q38151695 | ||
| γδ T cells: first line of defense and beyond | Q38175514 | ||
| Autoimmune pathogenesis of Chagas heart disease: looking back, looking ahead | Q38412987 | ||
| Production of MMP-9 and inflammatory cytokines by Trypanosoma cruzi-infected macrophages | Q38935265 | ||
| Cutting edge: dysfunctional CD8+ T cells reside in nonlymphoid tissues during chronic Trypanosoma cruzi infection. | Q39165193 | ||
| Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy | Q39269382 | ||
| Tumor-infiltrating IL-17-producing gammadelta T cells support the progression of tumor by promoting angiogenesis | Q39714121 | ||
| Administration of a nondepleting anti-CD25 monoclonal antibody reduces disease severity in mice infected with Trypanosoma cruzi | Q39829243 | ||
| Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis | Q39884132 | ||
| Trypanosoma cruzi Infection Imparts a Regulatory Program in Dendritic Cells and T Cells via Galectin-1-Dependent Mechanisms. | Q41022830 | ||
| Deficient NLRP3 and AIM2 Inflammasome Function in Autoimmune NZB Mice | Q41136957 | ||
| Depletion of regulatory T cells decreases cardiac parasitosis and inflammation in experimental Chagas disease | Q41552272 | ||
| Interferon-gamma gene expression in human B-cell lines: induction by interleukin-2, protein kinase C activators, and possible effect of hypomethylation on gene regulation | Q41612397 | ||
| Anti-CD4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn hearts grafted in mice chronically infected with Trypanosoma cruzi | Q41823109 | ||
| γδT cells drive myeloid-derived suppressor cell-mediated CD8+ T cell exhaustion in hepatitis B virus-induced immunotolerance | Q42206463 | ||
| Randomized trial of posaconazole and benznidazole for chronic Chagas' disease. | Q42215365 | ||
| CD1d-restricted help to B cells by human invariant natural killer T lymphocytes | Q42944844 | ||
| Toxoplasma gondii induces a T-independent IFN-gamma response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-alpha. | Q43870805 | ||
| Dual role for nitric oxide in paracoccidioidomycosis: essential for resistance, but overproduction associated with susceptibility | Q43968823 | ||
| Myeloid-derived suppressor cells are key players in the resolution of inflammation during a model of acute infection. | Q44662401 | ||
| An age-related gamma delta T cell suppressor activity correlates with the outcome of autoimmunity in experimental Trypanosoma cruzi infection. | Q45015838 | ||
| The involvement of CD4+CD25+ T cells in the acute phase of Trypanosoma cruzi infection. | Q45339719 | ||
| Identification of phenotypic markers of B cells from patients with Chagas disease | Q45341357 | ||
| Phenotypic features of peripheral blood leucocytes during early stages of human infection with Trypanosoma cruzi | Q47365806 | ||
| A novel subset of adult gamma delta thymocytes that secretes a distinct pattern of cytokines and expresses a very restricted T cell receptor repertoire | Q48054516 | ||
| Salmonella typhimurium induces IFN-gamma production in murine splenocytes. Role of natural killer cells and macrophages. | Q50163402 | ||
| TNF blockade aggravates experimental chronic Chagas disease cardiomyopathy. | Q51795933 | ||
| V gamma 1 gammadelta T cells regulate type-1/type-2 immune responses and participate in the resistance to infection and development of heart inflammation in Trypanosoma cruzi-infected BALB/c mice. | Q51984370 | ||
| Trypanosoma cruzi modulates the profile of memory CD8+ T cells in chronic Chagas' disease patients. | Q51985286 | ||
| NK1.1 cells are required to control T cell hyperactivity during Trypanosoma cruzi infection. | Q51998936 | ||
| NK1.1+ cells and T-cell activation in euthymic and thymectomized C57Bl/6 mice during acute Trypanosoma cruzi infection. | Q52014455 | ||
| In vivo maintenance of human regulatory T cells during CD25 blockade. | Q53002103 | ||
| Myeloid-derived suppressor cells infiltrate the heart in acute Trypanosoma cruzi infection. | Q54356491 | ||
| Leishmania amazonensis: participation of regulatory T and B cells in the in vitro priming (PIV) of CBA/J spleen cells susceptible response. | Q54615308 | ||
| Posaconazole versus Benznidazole for Chronic Chagas' Disease | Q56763224 | ||
| Autoimmunity | Q56772837 | ||
| Trypanosoma cruzi: Conformational Preferences of Antigenic Peptides Bearing the Immunodominant Epitope of the B13 Antigen | Q56772939 | ||
| Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10 | Q56987761 | ||
| Prostaglandins mediate suppression of lymphocyte proliferation and cytokine synthesis in acute Trypanosoma cruzi infection | Q58842426 | ||
| The role of the thymus in modulating gammadelta T cell suppressor activity during experimental Trypanosoma cruzi infection | Q58842855 | ||
| Posaconazole versus benznidazole for chronic Chagas' disease | Q58842899 | ||
| Posaconazole versus benznidazole for chronic Chagas' disease | Q58842903 | ||
| IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi | Q58843169 | ||
| Production of cytokine and chemokines by human mononuclear cells and whole blood cells after infection with Trypanosoma cruzi | Q58843593 | ||
| Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection | Q58843603 | ||
| The regulatory CD4+CD25+ T cells have a limited role on pathogenesis of infection with Trypanosoma cruzi | Q58844686 | ||
| B cells modulate T cells so as to favour T helper type 1 and CD8+ T-cell responses in the acute phase of Trypanosoma cruzi infection | Q58844820 | ||
| Increased plasma levels of tumor necrosis factor-alpha in asymptomatic/"indeterminate" and Chagas disease cardiomyopathy patients | Q58846005 | ||
| P433 | issue | 9 | |
| P921 | main subject | Trypanosoma cruzi | Q150162 |
| P304 | page(s) | ftv082 | |
| P577 | publication date | 2015-10-04 | |
| P1433 | published in | Pathogens and disease | Q27724629 |
| P1476 | title | Immunity and immune modulation in Trypanosoma cruzi infection | |
| P478 | volume | 73 |
| Q58701155 | Assessing the Effectiveness of Curative Benznidazole Treatment in Preventing Chronic Cardiac Pathology in Experimental Models of Chagas Disease |
| Q39010376 | Biological factors that impinge on Chagas disease drug development |
| Q41544597 | Chronic Chagas' Disease: Targeting the Interleukin-2 Axis and Regulatory T Cells in a Condition for Which There Is No Treatment |
| Q99711499 | Comparative Analysis of the Secretome and Interactome of Trypanosoma cruzi and Trypanosoma rangeli Reveals Species Specific Immune Response Modulating Proteins |
| Q55220404 | Correlation of transforming growth factor-β1 and tumour necrosis factor levels with left ventricular function in Chagas disease. |
| Q64987410 | Evaluation of pathogen P21 protein as a potential modulator of the protective immunity induced by Trypanosoma cruzi attenuated parasites. |
| Q59136942 | Limited Foxp3 Regulatory T Cells Response During Acute Infection Is Required to Allow the Emergence of Robust Parasite-Specific CD8 T Cell Immunity |
| Q55482216 | Orally-transmitted Chagas disease: Epidemiological, clinical, serological and molecular outcomes of a school microepidemic in Chichiriviche de la Costa, Venezuela. |
| Q39244146 | Participation of TLR2 and TLR4 in Cytokines Production by Patients with Symptomatic and Asymptomatic Chronic Chagas Disease. |
| Q57789637 | Pathology and Pathogenesis of Chagas Heart Disease |
| Q95841203 | Precision Health for Chagas Disease: Integrating Parasite and Host Factors to Predict Outcome of Infection and Response to Therapy |
| Q92542179 | Redox Balance Keepers and Possible Cell Functions Managed by Redox Homeostasis in Trypanosoma cruzi |
| Q54255041 | Regulatory Lymphoid and Myeloid Cells Determine the Cardiac Immunopathogenesis of Trypanosoma cruzi Infection. |
| Q26738824 | Scrutinizing the Biomarkers for the Neglected Chagas Disease: How Remarkable! |
| Q92311732 | TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas' heart disease |
| Q54257702 | Trypanosoma cruzi load in synanthropic rodents from rural areas in Chile. |
| Q47162312 | Unconventional Pro-inflammatory CD4+ T Cell Response in B Cell-Deficient Mice Infected with Trypanosoma cruzi. |
Search more.